Dana-Farber Cancer Institute (Dara-Farber), one of the world’s top comprehensive cancer treatment and research sites in Boston, affiliated with Harvard Medical School, is actually ranked…
Boston-based Dana-Farber Cancer Institute (DFCI) entered into a collaborative agreement with an Australian oncology-focused biotech called Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA) to investigate…
The Benderson family of Sarasota, Florida, donated $5 million to the Dana-Farber Cancer Institute in Boston, MA, representing the largest philanthropic gift addressing triple-negative breast…
Patients with acute or chronic graft-versus-host disease (GVHD) have several unmet needs, including later-line therapies. Novel agents and other research emerges as well. For the frontline…
William G. Kaelin, Jr. MD won the 2019 Nobel Prize in medicine. His research findings at Dana-Farber are game-changing: a rare disorder called von Hippel…
Young Dana-Farber investigators Jennifer Guerriero, PhD and Sarah Hill, MD, PhD are on a mission to find better treatments for breast, ovarian and other cancers.…
A surge of clinical trials with great potential for promising new treatments for T-cell lymphoma are based on significant basic research momentum made possible by…
The Dana-Farber Cancer Institute has received a $5 million gift from the Edward P. Evans Foundation in support of research on myelodysplastic syndromes (MDS). What…
ImaginAB Inc., a Los Angeles-based, immune-oncology imaging company focused on offering actionable insight into patient selection and treatment for cancer immunotherapy, enabling precision medicine to…
Dana-Farber Cancer Institute’s Guru P Sonpavde explains what clinical trials are and who they may be appropriate for. Dr. Sonpavde, an esteemed oncologist, works for…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
